Gene · 2114
Papers2,490
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 2,490
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Assessment of Telomerase Reverse Transcriptase Single Nucleotide Polymorphism in Sleep Bruxism. | J Clin Med | 2022 | 35159976 | PubTator, text mining | PubMed |
| The Role of p53 Family in Cancer. | Cancers (Basel) | 2022 | 35159090 | PubTator, text mining | PubMed |
| Recovery of Dysregulated Genes in Cancer-Related Lower Limb Lymphedema After Supermicrosurgical Lymphaticovenous Anastomosis - A Prospective Longitudinal Cohort Study. | J Inflamm Res | 2022 | 35153500 | PubTator, text mining | PubMed |
| The MuvB complex safeguards embryonic stem cell identity through regulation of the cell cycle machinery. | J Biol Chem | 2022 | 35148988 | PubTator, text mining | PubMed |
| Prediction of transcription factors associated with DNA demethylation during human cellular development. | Chromosome Res | 2022 | 35142952 | PubTator, text mining | PubMed |
| Blood and brain transcriptome analysis reveals APOE genotype-mediated and immune-related pathways involved in Alzheimer disease. | Alzheimers Res Ther | 2022 | 35139885 | PubTator, text mining | PubMed |
| Screening Gene Expression-Related Alternative Splicing Event Signature for Colon Cancer Prognostic Prediction. | J Oncol | 2022 | 35126520 | PubTator, text mining | PubMed |
| TLR13 contributes to skeletal muscle atrophy by increasing insulin resistance in chronic kidney disease. | Cell Prolif | 2022 | 35088922 | PubTator, text mining | PubMed |
| Splice variants denote differences between a cancer stem cell side population of EWSR1‑ERG‑based Ewing sarcoma cells, its main population and EWSR1‑FLI‑based cells. | Int J Mol Med | 2022 | 35088879 | PubTator, text mining | PubMed |
| iMyoblasts for ex vivo and in vivo investigations of human myogenesis and disease modeling. | Elife | 2022 | 35076017 | PubTator, text mining | PubMed |
| Identifying changes in immune cells and constructing prognostic models using immune-related genes in post-burn immunosuppression. | PeerJ | 2022 | 35070500 | PubTator, text mining | PubMed |
| Multiple ETS Factors Participate in the Transcriptional Control of TERT Mutant Promoter in Thyroid Cancers. | Cancers (Basel) | 2022 | 35053525 | PubTator, text mining | PubMed |
| The Role and Research Progress of Inhibitor of Differentiation 1 in Atherosclerosis. | DNA Cell Biol | 2022 | 35049366 | PubTator, text mining | PubMed |
| Genetic and Transcriptional Contributions to Relapse in Normal Karyotype Acute Myeloid Leukemia. | Blood Cancer Discov | 2022 | 35019859 | PubTator, text mining | PubMed |
| RegEnrich gene regulator enrichment analysis reveals a key role of the ETS transcription factor family in interferon signaling. | Commun Biol | 2022 | 35017649 | PubTator, text mining | PubMed |
| Lifelong single-cell profiling of cranial neural crest diversification in zebrafish. | Nat Commun | 2022 | 35013168 | PubTator, text mining | PubMed |
| The landscape of human tissue and cell type specific expression and co-regulation of senescence genes. | Mol Neurodegener | 2022 | 35000600 | PubTator, text mining | PubMed |
| Prenatal and Postnatal Pharmacotherapy in Down Syndrome: The Search to Prevent or Ameliorate Neurodevelopmental and Neurodegenerative Disorders. | Annu Rev Pharmacol Toxicol | 2022 | 34990205 | PubTator, text mining | PubMed |
| Neurogenetic disorders across the lifespan: from aberrant development to degeneration. | Nat Rev Neurol | 2022 | 34987232 | PubTator, text mining | PubMed |
| p53 mutations define the chromatin landscape to confer drug tolerance in pancreatic cancer. | Mol Oncol | 2022 | 34919788 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2114/papers?page=24